Navigation Links
Study offers window into human behavior, brain disease

of von Economo neurons and neighboring neurons in the anterior cingulate cortex, looking specifically at brain tissue from three sets of deceased patients -- seven who had no neurological disease, five who had Alzheimer's disease and seven who had frontotemporal dementia.

The results were striking. In frontotemporal dementia, there was early, severe and selective loss of von Economo neurons compared to control subjects. In Alzheimer's disease, von Economo neurons were not significantly depleted.

"This finding provides new insight into how frontotemporal dementia erodes the brain at the cellular level," says the first author of the study, William Seeley, MD, UCSF instructor of neurology and a clinician-scientist at the UCSF Memory and Aging Center.

Progress has been made in illuminating some of the genetic and molecular aspects of the disease ?two mutated genes are associated with most inherited forms of the disease and major misprocessed proteins have been identified ?but "discoveries at the genetic and molecular level do not yet explain why specific populations of neurons are dying," he says.

"This observation gives us a new window into the early and cell-specific degenerative process, and we can use this window to better understand disease pathogenesis."

The team, led by Seeley, is currently trying to study von Economo neuron-rich regions in living patients using neuroimaging. They also are studying VENs, themselves, in autopsy studies using neuropathological techniques.

As FTD is a disease for which there is as yet no disease-modifying therapy, studies of von Economo neurons could provide new strategies.

Why the cells are vulnerable is still a mystery, says Seeley. But given the fact that they are evolutionarily new, the explanation may be that there are still "kinks" in the genetic programming of the neuronal circuits.

"VENs probably help us in some wonderful way, which would explai
'"/>

Source:University of California - San Francisco


Page: 1 2 3 4

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
3. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
4. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
5. Study Links Ebola Outbreaks To Animal Carcasses
6. Breakthrough Microarray-based Technology for the Study of Cancer
7. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
8. Study finds more than one-third of human genome regulated by RNA
9. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
10. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
11. New Study from Affymetrix Laboratories Points to Changing View of How Genome Works

Post Your Comments:
(Date:11/30/2009)... of lower early bird registration rates and regist...ss of 2010 at http://www.iofwco-ecceo10.org/ ,... International Osteoporosis Foundation (IOF) and t...cts of Osteoporosis and Osteoarthritis (ESCEO). Mo...re expected to attend. The exciting scientific pro...
(Date:11/30/2009)..., VILNIUS, Lithuania, Nov. 30 Neu... provider of high-precision biometric identificati...the company,s core product line: VeriLook 4.0 So...n and MegaMatcher 3.1 SDK for large-scale multi-... systems (AFIS). Expanded capabilities in VeriLook...
(Date:11/26/2009)...e at last worked out a way of using recordings of ...pulations. This is the first time sound recordings... accurate estimates of bird species, populations. ... Ecological Society,s Journal of Applied Ecology ... a major advance in our ability to monitor whale a...
Breaking Biology News(10 mins):New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 3Ecologists sound out new solution for monitoring cryptic species 2Steven Holtzman Joins Satori Pharmaceuticals Board of Directors 56134 1Steven Holtzman Joins Satori Pharmaceuticals Board of Directors 56134 2Steven Holtzman Joins Satori Pharmaceuticals Board of Directors 56134 3Steven Holtzman Joins Satori Pharmaceuticals Board of Directors 56134 4Encap agrees colonic drug delivery licensing deal 9775 1Encap agrees colonic drug delivery licensing deal 9775 2Encap agrees colonic drug delivery licensing deal 9775 3Sinovac Obtains Production License for H1N1 Vaccine 13826 1Sinovac Obtains Production License for H1N1 Vaccine 13826 2Sinovac Obtains Production License for H1N1 Vaccine 13826 3
...ntal enrichment and increased social stress can bo...ing to new monkey research at Wake Forest Universi... shown that social rank whether animals are domin... affect the amount of cocaine that monkeys will se...molgus monkeys will invariably stratify by social ...
...hers report today in the journal Nature Genetics t...s can be associated with a dramatically lower risk...population. , The insight that rare mutations may... of common yet complex diseases such as hypertensi...atment of diseases such as diabetes and schizophre...
...esperately try to reach for a break in the canopy ...ffliction: Shade avoidance syndrome or SAS. Now, t...ight by researchers at the Salk Institute for Biol... shade, plants switch on a natural chemical factor...xin that lets a plant grow and ultimately stretch ...
Other Biology News:Environmental enrichment can reduce cocaine use, researchers find 2Yale study shows how rare genes have big impact on blood pressure 2A place in the sun 2A place in the sun 3
(Date:11/30/2009)...G OF PRUSSIA, Pa., Nov. 30 Cadien...zing in interactive marketing services and soluti...he launch of its HATCH Consulting services g...ng strategic experts across a range of emerging ar...nsulting team is committed to guiding companies an...
(Date:11/30/2009)...CLIFF MANOR, N.Y., Nov. 30 Good Pu...nt for the publication of company-sponsored medica... British Medical Journal (BMJ). "The publication o...nce of providing support and guidance for industry...esults in the peer-reviewed medical literature," s...
(Date:11/30/2009)... Md., Nov. 30 Novavax, I...ted enrollment in the Phase II clinical study of i...nded strains) VLP vaccine candidate in healthy adu... randomized, double-blind, active-controlled study...enicity of two different doses (15 mcg and 60 mcg)...
(Date:11/30/2009)...d COPENHAGEN, Nov. 30 Exiqon A/S (... the Harvard Medical School ICCB-Longwood Screenin...RNA Screening Center of Excellence. ICCB-L suppor...sociated hospitals and institutions, for high-thro...ies. ,, MicroRNAs are a novel class of small, n...
Breaking Biology Technology:Cadient Interactive Announces the Launch of HATCH Consulting Services 2Cadient Interactive Announces the Launch of HATCH Consulting Services 3ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 2ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3
...X: ARPN) today announced that the European Medicin...ting Authorisation Application (MAA) for,intraveno...nous iclaprim in,the European Union for the treatm... (cSSTI). Iclaprim is a hospital antibiotic drug c...ty against MRSA and an extended range,of important...
...s 27th annual Inc. 500 ranking of the fastest-grow...rmation Technology (IT) services provider,MicroTec...th of 1078.5%., The 2008 Inc. 500 list measures r...companies had to be U.S.-based, privately held, in...companies - and have had at least,$200,000 in net ...
...ems,(MMS) today announced a new partnership with t...e result of a legislative initiative that,establis...enefit for North,Dakota state employees and other ... Pharmaceutical Care System(TM) will provide North...ing and technology to guide and,document the deliv...
Other Biology Technology:Arpida's iclaprim MAA Accepted for Review by EMEA 2Arpida's iclaprim MAA Accepted for Review by EMEA 3MicroTech Ranks No. 285 on Inc. Magazine's 2008 List of the 500 Fastest Growing Private Companies in America 2North Dakota Pharmacists and Medication Management Systems Partner to Deliver Quality MTM Services to Patients With Diabetes 2
Goat Anti-Zebrafish Ephrin-B2 Polyclonal Antibody, Biotin Conjugated from R&D Systems
PhotoMan Direct Copy Hood and UV Shield set, 10 x 12 cm from Hoefer, Inc.
Donor Goat Serum from Lifeblood Medical, Inc.
GeneRacer Kit with SuperScript II RT and Zero Blunt TOPO PCR Cloning kit for Sequencing from Invitrogen
Biology Products: